Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biphasic Insulin Aspart 50 vs 30 with Metformin in Chinese T2D
NCT00627445Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Feb 2008
- Primary completion
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Feb 2008; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00627445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00627445.